Tumor Necrosis Factor-alpha Blocker Monotherapy or In Combination with Immunomodulators or Systemic Corticosteroids Does not Augment the Risk of Bacterial Infections: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01610 ◽

2012 ◽

Vol 107 ◽

pp. S650

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Bacterial Infections ◽

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Systemic Corticosteroids ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Differentiating the Risk of Bacterial Infections between Individual Tumor Necrosis Factor-alpha (TNF-α) Blockers in Inflammatory Bowel Disease: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01608 ◽

2012 ◽

Vol 107 ◽

pp. S649-S650

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Bacterial Infections ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Tnf Α ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Su1154 Maternal and Fetal Adverse Outcomes With Tumor Necrosis Factor Alpha Inhibitors in Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

Gastroenterology ◽

10.1016/s0016-5085(13)61521-8 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-413 ◽

Cited By ~ 2

Author(s):

Parakkal Deepak ◽

Derrick J. Stobaugh ◽

Eli D. Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Adverse Outcomes ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

T-Cell Lymphomas in the Era of Tumor Necrosis Factor Alpha (TNF-α) Inhibition: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS): Results of the REFURBISH study: ACG Lawlor Resident Award

The American Journal of Gastroenterology ◽

10.14309/00000434-201110002-01286 ◽

2011 ◽

Vol 106 ◽

pp. S489

Author(s):

Deepak Parakkal ◽

Humberto Sifuentes ◽

Muhammed Sherid ◽

Yama Sadozai ◽

Eli Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

T Cell Lymphomas ◽

Tnf Α ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Analysis of the Food and Drug Administration Adverse Event Reporting System to Examine the Relationship between Tumor Necrosis Factor Alpha Inhibitor Therapy and Congestive Heart Failure among Patients with Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-01726 ◽

2013 ◽

Vol 108 ◽

pp. S520-S521

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

The Relationship ◽

Necrosis Factor

Download Full-text

Tumor Necrosis Factor-Alpha Blockers do not Augment the Risk of Viral Infection in Inflammatory Bowel Disease (IBD): A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01578 ◽

2012 ◽

Vol 107 ◽

pp. S636-S637

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Alpha Blockers ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Mo1198 Risk of Pancreatitis With Tumor Necrosis Factor-Alpha Inhibitors Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

Gastroenterology ◽

10.1016/s0016-5085(14)62114-4 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-583-S-584

Author(s):

Derrick J. Stobaugh ◽

Salih Samo ◽

Parakkal Deepak ◽

Eli D. Ehrenpreis

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Su1161 Risk of Solid Cancers With Tumor Necrosis Factor Alpha Inhibitor Therapy Among Inflammatory Bowel Disease Patients: An Analysis of the Food and Drug Administration Adverse Event Reporting System

Gastroenterology ◽

10.1016/s0016-5085(13)61528-0 ◽

2013 ◽

Vol 144 (5) ◽

pp. S-416

Author(s):

Derrick J. Stobaugh ◽

Parakkal Deepak ◽

Eli D. Ehrenpreis

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Tumor Necrosis Factor-alpha (TNF-α) Blocker Monotherapy and in Combination with Immunomodulators and Corticosteroids, Augment the Risk of Mycobacterial Infections: A Review of the Food and Drug Administration Adverse Event Reporting System (FDA AERS)

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01607 ◽

2012 ◽

Vol 107 ◽

pp. S649

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Tumor Necrosis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Mycobacterial Infections ◽

Tnf Α ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

Analysis of Drug-induced Liver Injury Reported with Tumor Necrosis Factor-alpha Inhibitors to the Food and Drug Administration Adverse Event Reporting System in Inflammatory Bowel Disease

The American Journal of Gastroenterology ◽

10.14309/00000434-201310001-01705 ◽

2013 ◽

Vol 108 ◽

pp. S513

Author(s):

Parakkal Deepak ◽

Derrick Stobaugh ◽

Eli Ehrenpreis

Keyword(s):

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Drug Induced ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Drug Induced Liver Injury ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor

Download Full-text

New-Onset Inflammatory Bowel Disease During Tumor Necrosis Factor-Alpha Inhibitor Therapy for Rheumatoid Arthritis and Juvenile Rheumatoid Arthritis: A Review of the Food and Drug Administration Adverse Event Reporting System and Literature

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-01545 ◽

2012 ◽

Vol 107 ◽

pp. S621-S622

Author(s):

Lena Gong ◽

Derrick Stobaugh ◽

Parakkal Deepak ◽

Eli Ehrenpreis

Keyword(s):

Rheumatoid Arthritis ◽

Reporting System ◽

Adverse Event Reporting System ◽

Adverse Event Reporting ◽

Necrosis Factor Alpha ◽

Event Reporting ◽

Inflammatory Bowel ◽

Factor Alpha ◽

Necrosis Factor ◽

New Onset

Download Full-text